Cas:90565-27-8 1-(3-Pyridinyl)-1-butanamine manufacturer & supplier

We serve Chemical Name:1-(3-Pyridinyl)-1-butanamine CAS:90565-27-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-(3-Pyridinyl)-1-butanamine

Chemical Name:1-(3-Pyridinyl)-1-butanamine
CAS.NO:90565-27-8
Synonyms:1-pyridin-3-yl-butylamine;1-piperidin-3-yl-ethanone;1-Piperidin-3-Yl-Ethanone Hydrochloride;3-Acetyl-piperidin
Molecular Formula:C9H14N2
Molecular Weight:150.22100
HS Code:2933399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:38.91000
Exact Mass:150.11600
LogP:2.58180

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-pyridin-3-yl-butylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Acetyl-piperidin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-piperidin-3-yl-ethanone Use and application,1-piperidin-3-yl-ethanone technical grade,usp/ep/jp grade.


Related News: The results of analysis perfectly align with the tau hypothesis — simply put, if the patient is tau biomarker positive, then tau pathology is responsible for his/her cognitive decline, and halting tau pathology should slow or halt progression,” Novak said. “If the patient is negative for markers of tau pathology, then this patient’s impairment is mainly due to other pathologies, and treating tau pathology in this patient won’t be meaningful. 1-(3-Pyridinyl)-1-butanamine manufacturer This decision has shaken the foundations of the scientific process and methods, said Dr. Jason Karlawish, co-director of the Penn Memory Center in Philadelphia. Karlawish ran one of the trial sites for the Biogen drug. 1-(3-Pyridinyl)-1-butanamine supplier This decision has shaken the foundations of the scientific process and methods, said Dr. Jason Karlawish, co-director of the Penn Memory Center in Philadelphia. Karlawish ran one of the trial sites for the Biogen drug. 1-(3-Pyridinyl)-1-butanamine vendor The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances. 1-(3-Pyridinyl)-1-butanamine factory The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term.